Eric S. Lander
Oprichter bij Massachusetts Institute of Technology
Profiel
Eric S.
Lander is the founder of Foundation Medicine, Inc. (2009), Verastem, Inc. (2010), Massachusetts Institute of Technology (1990), Infinity Discovery, Inc. (2001), The Broad Institute, Inc. (2003), BioNTech US, Inc. (2013), and Codiak BioSciences, Inc. (2015).
He holds the title of Professor-Biology at Massachusetts Institute of Technology from 1990 to present.
Dr. Lander's current jobs include Director at The Innocence Project and Professor-System Biology at Harvard Medical School.
Dr. Lander's former jobs include Director at Millennium Pharmaceuticals, Inc. (1993-2007), Independent Director at Infinity Pharmaceuticals, Inc. (2011-2016), Director at Whitehead Institute for Biomedical Research (1986-2010), and Strategic Advisor at The Courtagen Group LLC.
Dr. Lander received a doctorate degree from the University of Oxford in 1981 and an undergraduate degree from Princeton University.
Actieve functies van Eric S. Lander
| Bedrijven | Functie | Begin |
|---|---|---|
| Massachusetts Institute of Technology | Oprichter | 01-01-1990 |
| Harvard Medical School | Corporate Officer/Principal | 01-01-2004 |
| The Innocence Project | Directeur/Bestuurslid | - |
Eerdere bekende functies van Eric S. Lander
| Bedrijven | Functie | Einde |
|---|---|---|
| CODIAK BIOSCIENCES | Oprichter | 25-01-2021 |
| NEON THERAPEUTICS, INC. | Oprichter | 06-05-2020 |
| INFINITY PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-11-2016 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | 10-05-2007 |
| Infinity Discovery, Inc. | Oprichter | 12-09-2006 |
Opleiding van Eric S. Lander
| University of Oxford | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| VERASTEM, INC. | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
| Infinity Discovery, Inc. | |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
The Courtagen Group LLC
 The Courtagen Group LLC Investment ManagersFinance Courtagen Group LLC is a venture capital firm located in Charlestown, Massachusetts. | Finance |
| The Innocence Project | |
BioNTech US, Inc.
 BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
